Theratechnologies (TSE:TH) Hits New 12-Month High – Here’s What Happened

Theratechnologies Inc. (TSE:TH)’s share price reached a new 52-week high on Tuesday . The company traded as high as C$3.13 and last traded at C$3.08, with a volume of 88466 shares traded. The stock had previously closed at C$2.91.

Theratechnologies Trading Up 2.4 %

The company has a 50 day moving average of C$2.04 and a two-hundred day moving average of C$1.90. The stock has a market capitalization of C$137.02 million, a PE ratio of -16.56, a P/E/G ratio of -8.50 and a beta of 1.73. The company has a debt-to-equity ratio of 562.07, a quick ratio of 0.64 and a current ratio of 1.10.

Theratechnologies (TSE:TH) last issued its quarterly earnings results on Thursday, October 10th. The company reported C$0.09 earnings per share for the quarter. Theratechnologies had a negative return on equity of 1,116.86% and a negative net margin of 8.47%. The business had revenue of C$30.96 million for the quarter. Sell-side analysts predict that Theratechnologies Inc. will post 0.0298643 EPS for the current year.

Theratechnologies Company Profile

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.